Advertisement
JOGC
Health Policy/Ethics| Volume 38, ISSUE 5, P470-482, May 2016

A Review of Consent Documents From Canadian IVF Clinics, 1991 to 2014

Published:April 29, 2016DOI:https://doi.org/10.1016/j.jogc.2016.02.008

      Abstract

      Objective

      We reviewed the content of IVF consent documents (i.e., consent forms and accompanying information sheets) used by Canadian IVF clinics in 1991, 2004, and 2014, paying particular attention to the inclusion of information that should be provided to patients in accordance with minimum ethical standards for disclosure.

      Methods

      We contacted all Canadian IVF clinics in operation in 1991 (17 clinics), 2004 (24 clinics), and 2014 (35 clinics) by mail and requested blank copies of their IVF consent documents. Documents received were reviewed for the inclusion of information about the nature of IVF, the potential benefits of IVF, the potential harms and inconveniences of IVF, confidentiality, voluntariness, and options for the use or discarding of embryos not transferred in the original stimulated cycle (sometimes referred to as supernumerary, excess, or spare embryos).

      Results

      We received responses from 11 of 17 clinics operating in 1991 (response rate 65%), 14 of 24 clinics operating in 2004 (response rate 58%), and 11 of 35 clinics operating in 2014 (response rate 31%). In general, comparisons of the 1991, 2004, and 2014 data sets showed a long-term decrease in documented disclosure of information that should be provided to patients in accordance with minimum ethical standards. The only cases in which this trend appeared to be reversed was with disclosure about the probability of supernumerary embryos, long-term risks of treatment, the right to revoke consent to the use or discarding of supernumerary embryos, and some of the options for the use of supernumerary embryos. In these few instances, there was a notable improvement in the disclosure of relevant information between 1991 and 2014.

      Conclusion

      The disclosure of information relevant to the interests of those undergoing IVF and those who are born as a result of IVF appears to be decreasing. Furthermore, the information that increasingly is being disclosed in consent documents appears to be directing the orientation and content of these documents away from the primary interests of the relevant women, couples, and children. These two trends are inconsistent with the goal of informed consent.

      Résumé

      Objectif

      Nous avons examiné le contenu de documents de consentement à la FIV (formulaires de consentement et fiches d’information complémentaire) utilisés par les cliniques canadiennes de FIV en 1991, 2004 et 2014. Nous avons accordé une attention particulière à l’inclusion des renseignements qu’on devrait fournir aux patientes, conformément aux normes de déontologie minimales de divulgation.

      Méthodes

      Nous avons communiqué par la poste avec toutes les cliniques canadiennes de FIV qui étaient en service en 1991 (17 cliniques), en 2004 (24 cliniques) et en 2014 (35 cliniques), en leur demandant de nous fournir une copie vierge de leurs documents de consentement à la FIV. Nous avons examiné les documents reçus afin de déterminer l’inclusion de renseignements sur la nature de la FIV, les avantages potentiels de la FIV, les dangers et les inconvénients potentiels de la FIV, la confidentialité, le caractère volontaire du consentement, ainsi que les options d’utilisation ou d’élimination des embryons non transférés (parfois désignés par les expressions « embryons surnuméraires », ou « embryons excédentaires ») lors du cycle de stimulation d’origine.

      Résultats

      Nous avons reçu des réponses de 11 des 17 cliniques en service en 1991 (taux de réponse de 65 %), de 14 des 24 cliniques en service en 2004 (taux de réponse de 58 %) et de 11 des 35 cliniques en service en 2014 (taux de réponse de 31 %). En général, la comparaison des ensembles de données de 1991, de 2004 et de 2014 a révélé une régression à long terme de la divulgation documentée des renseignements qu’on devrait fournir aux patientes, conformément aux normes de déontologie minimales. Les seuls cas dans lesquels cette tendance a semblé être inversée sont ceux qui traitent de la divulgation des probabilités relatives à la production d’embryons surnuméraires, des risques à long terme du traitement, du droit de révocation du consentement à l’utilisation ou à l’élimination des embryons surnuméraires, ainsi que de certaines des options d’utilisation des embryons surnuméraires. Dans ces rares cas, nous avons constaté une amélioration notable de la divulgation de renseignements pertinents entre 1991 et 2014.

      Conclusion

      La divulgation de l’information qui servirait les intérêts des personnes qui se soumettent à la FIV et de celles qui naissent grâce à la FIV semble aller en s’amenuisant. En outre, les renseignements de plus en plus divulgués dans les documents de consentement semblent en détourner l’orientation et le contenu des intérêts fondamentaux des femmes, des couples et des enfants concernés. Ces deux tendances entrent en contradiction avec le but du consentement éclairé.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Obstetrics and Gynaecology Canada
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Royal Commission on New Reproductive Technologies
        Proceed with care. Final report of the Royal Commission on New Reproductive Technologies (RCNRT). Vols. 1-2. Ministry of Supply and Services, ON, Ottawa1993
      1. Canadian Fertility and Andrology Society and Society of Obstetricians and Gynaecologists of Canada. Joint policy statement: ethical issues in assisted reproduction. Available at: https://www.cfas.ca/index.php?option=com_content&view=article&id=1116&Itemid=686. Accessed on October 26, 2015.

      2. Department of Justice, Canada. Assisted Human Reproduction Act, 2004 c.2. Available at: http://laws.justice.gc.ca/en/a-13.4/2294.html. Accessed on October 26, 2015.

      3. Canadian Legal Information Institute. Assisted Human Reproduction (Section 8 Consent) Regulations, SOR/2007-137. CanLII. Updated June 14, 2007. Available at: http://www.canlii.org/en/ca/laws/regu/sor-2007-137/latest/sor-2007-137.html. Accessed on October 26, 2015.

        • Baylis F.
        Assisted reproductive technologies: informed choice.
        in: Research studies of the Royal Commission on New Reproductive Technologies-volume 1: new reproductive technologies: ethical aspects. Minister of Supply and Services, Canada, Ottawa1993: 47-147
        • Lidz C.W.
        • Appelbaum P.S.
        • Meisel A.
        Two models of implementing informed consent.
        Arch Intern Med. 1988; 148: 1385-1389
        • Berg J.W.
        • Appelbaum P.S.
        • Lidz C.W.
        • Parker L.S.
        Informed consent: legal theory and clinical practice.
        ed 2. Oxford University Press, Oxford2001
      4. The College of Physicians and Surgeons of Ontario. Consent to medical treatment. Available at: www.cpso.on.ca/uploadedFiles/policies/policies/policyitems/Consent.pdf. Accessed on October 26, 2015.

        • Rozovsky L.E.
        The Canadian law of consent to treatment.
        ed 3. LexisNexis Butterworths, Toronto2003
        • Ali V.
        Consent forms as part of the informed consent process: moving away from “medical Miranda.”.
        Hastings Law J. 2003; 54: 1575-1591
        • Raab E.L.
        The parameters of informed consent.
        Trans Am Ophthalmol Soc. 2004; 102: 225-230
        • Fischbach R.L.
        • Sionelo-Bayog A.
        • Needle A.
        • Delbanco T.L.
        The patient and practitioner as co-authors of the medical record.
        Patient Couns Health Educ. 1980; 2: 1-5
        • Dawes P.J.
        • O'Keefe L.
        • Adcock S.
        Informed consent: using a structured interview changes patients' attitudes towards informed consent.
        J Laryngol Otol. 1993; 107: 775-779
        • Bottrell M.M.
        • Alpert H.
        • Fischbach R.L.
        • Emanuel L.L.
        Hospital informed consent for procedure forms: facilitating quality patient-physician interaction.
        Arch Surg. 2000; 135: 26-33
        • Deber R.B.
        • Bouchard H.
        • Pendleton A.
        Implementing shared decision making: a review of the literature.
        in: Research studies of the Royal Commission on New Reproductive Technologies-volume 10: treatment of infertility: current practices and psychosocial implications. Minister of Supply and Services, Canada, Ottawa1993: 341-433
        • Lynöe N.
        • Sandlund M.
        • Dahlqvist G.
        • Jacobsson L.
        Informed consent: study of quality of information given to participants in a clinical trial.
        BMJ. 1991; 303: 610-613
        • Askew G.
        • Pearson K.W.
        • Cryer D.
        Informed consent: can we educate patients?.
        J R Coll Surg Edinb. 1990; 35: 308-310
        • Armstrong A.P.
        • Cole A.A.
        • Page R.E.
        Informed consent: are we doing enough?.
        Br J Plast Surg. 1997; : 637-640
        • Langdon I.J.
        • Hardin R.
        • Learmonth I.D.
        Informed consent for total hip arthroplasty: does a written information sheet improve recall by patients?.
        Ann R Coll Surg Engl. 2002; 84: 404-408
        • Cunningham
        • Swan
        • Carty
        • Little & Bonham (Kingston, ON)
        Consent to treatment section of Consent and negligence chapter (loose-leaf revision 238, May 2012).
        in: Rozovsky L. Rozovsky F.A. Canadian health facilities law guide. LexisNexis, Toronto, ON2012: 1501-1511 (1525–53)
        • Nelson E.
        The fundamentals of consent.
        in: Downie J.G. Caulfield T.A. Flood C.M. Canadian health law and policy. ed 2. Butterworths, Markham, ON2002: 111-128
      5. Canadian Legal Information Institute. Toews v. Weisner and South Fraser Health Region, BCSC 15. Available at: http://canlii.ca/t/1fm4t. Accessed on October 26, 2015.

        • Freedman B.
        A moral theory of consent.
        in: Boetzkes E. Waluchow W.J. Readings in health care ethics. Broadview Press, Peterborough, ON2000: 127-137
        • Capron A.M.
        Informed decisionmaking in genetic counseling: a dissent to the “wrongful life” debate.
        Indiana Law J. 1973; 48: 581-604
        • Dancet E.A.
        • van Empel I.
        • Rober P.
        • Nelen W.L.
        • Kremer J.A.
        • D'Hooghe T.M.
        Patient-centred infertility care: a qualitative study to listen to the patient's voice.
        Hum Reprod. 2011; 26: 827-833
        • van Empel I.
        • Dancet E.A.
        • Koolman X.H.
        • Nelen W.L.
        • Stolk E.A.
        • Sermeus W.
        • et al.
        Physicians underestimate the importance of patient-centredness to patients: a discrete choice experiment in fertility care.
        Hum Reprod. 2011; 26: 584-593
        • Pfeffer N.
        Are British IVF consent forms adequate?.
        Bull Med Ethics. 1991; 69: 28-31
        • Turiel J.S.
        Beyond second opinions: making choices about fertility treatment.
        University of California Press, Berkeley1998
        • Su T.J.
        • Chen Y.C.
        Transforming hope: the lived experience of infertile women who terminated treatment after in vitro fertilization failure.
        J Nurs Res. 2006; 14: 46-54
        • Nelson E.
        • Mykitiuk R.
        • Nisker J.
        • Christilaw J.
        • Corey J.A.
        • Heaman M.
        • et al.
        Informed consent to donate embryos for research purposes.
        J Obstet Gynaecol Can. 2008; 30: 824-836
        • Dickens B.
        Informed consent.
        in: Downie J. Caulfield T. Flood C. Canadian health law and policy. Butterworths, Markham, ON2002: 129-156
        • de Melo-Martin I.
        Free informed consent and in vitro fertilization. Making babies: biomedical technologies, reproductive ethics, and public policy.
        Kluwer Academic Publishers, Dodrecht, The Netherlands1998: 162-191
        • Pfeffer N.
        The uninformed conception.
        New Sci. 1991; 131: 40-41
        • Morris G.H.
        Dissing disclosure: just what the doctor ordered.
        Ariz Law Rev. 2002; 44: 313-371
        • Bhutta Z.A.
        Beyond informed consent.
        Bull World Health Organ. 2004; 82: 771-778
        • Rosenfeld Y.
        • Strulov A.
        Informed consent, Israel 2008—is it informed? The case of in vitro fertilization and embryo transfer.
        Isr Med Assoc J. 2009; 11: 407-410
        • Meisel A.
        • Kuczewski M.
        Legal and ethical myths about informed consent.
        Arch Intern Med. 1996; 156: 2521-2526
        • Kuczewski M.G.
        Reconceiving the family. The process of consent in medical decisionmaking.
        Hastings Cent Rep. 1996; 26: 30-37
        • Streiffer R.
        Reply to Robertson, Cohen and Hyun - Big bang theory: more reasons to scrap Bush's stem cell policy.
        Hastings Cent Rep. 2008; 38: 6